Rosetta Genomics Moving Higher, May be Attributed to Award of Patent for Treating Hematopoietic Malignancies
and no PR yet
Sentiment: Strong Buy
Not from the company, BUT "fly on the wall" has it on their website
Good news pours in from every direction. Having this stock is an amazing thing.